Overview

• Spain has not recorded any local chikungunya cases but SEIMC experts warn that importation risk is elevated due to nearby outbreaks and global spreads
• France has confirmed 49 autochthonous chikungunya cases and Italy two, triggering intensified monitoring in border regions
• A chikungunya vaccine from Bavarian Nordic has shown over 85% efficacy in trials and could become available pending regulatory approval
• The WHO and PAHO highlight that climate change and increased travel are expanding Aedes aegypti and albopictus mosquito habitats, raising transmission risks
• Spanish health authorities have stepped up vector control measures and public guidance on repellents and protective clothing to prevent potential outbreaks